Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis
- PMID: 17387214
- PMCID: PMC2092469
- DOI: 10.1136/thx.2006.060889
Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis
Abstract
With the improving survival of patients with cystic fibrosis (CF), the clinical spectrum of this complex multisystem disease continues to evolve. One of the most important clinical events for patients with CF in the course of this disease is an acute pulmonary exacerbation. Clinical and microbial epidemiology studies of CF pulmonary exacerbations continue to provide important insight into the course, prognosis and complications of the disease. This review provides a summary of the pathophysiology, clinical epidemiology and microbial epidemiology of a CF pulmonary exacerbation.
Conflict of interest statement
Competing interests: None.
Comment in
-
Pulmonary exacerbations in cystic fibrosis and bronchiectasis.Thorax. 2007 Apr;62(4):288-90. doi: 10.1136/thx.2006.065664. Thorax. 2007. PMID: 17387213 Free PMC article.
References
-
- Ferkol T, Rosenfeld M, Milla C E. Cystic fibrosis pulmonary exacerbations. J Pediatr 2006148259–264. - PubMed
-
- Boucher R C. New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 200423146–158. - PubMed
-
- Mall M, Grubb B R, Harkema J R.et al Increased airway epithelial Na+ absorption produces cystic fibrosis‐like lung disease in mice. Nat Med 200410487–493. - PubMed
-
- Donaldson S H, Bennett W D, Zeman K L.et al Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 2006354241–250. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical